![Philippe Sourdille](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Philippe Sourdille
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Ciliatech SAS
![]() Ciliatech SAS Medical/Nursing ServicesHealth Services Ciliatech SAS is a French company that has developed CID, an implant that reduces IntraOcular Pressure (IOP) without penetrating the anterior chamber or creating subconjunctival filtration. The company is based in Chavanod, France. This implant overcomes the most serious complications and shortcomings of other glaucoma surgical techniques. The company was founded in 2017 by Olivier Benoit, Philippe Sourdille. Olivier Benoit has been the CEO since 2017. | Hoofd Techniek/Wetenschap/O&O | 01-01-2017 | - |
Oprichter | 01-01-2017 | - |
Loopbaan van Philippe Sourdille
Statistieken
Internationaal
Frankrijk | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoraal
Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Ciliatech SAS
![]() Ciliatech SAS Medical/Nursing ServicesHealth Services Ciliatech SAS is a French company that has developed CID, an implant that reduces IntraOcular Pressure (IOP) without penetrating the anterior chamber or creating subconjunctival filtration. The company is based in Chavanod, France. This implant overcomes the most serious complications and shortcomings of other glaucoma surgical techniques. The company was founded in 2017 by Olivier Benoit, Philippe Sourdille. Olivier Benoit has been the CEO since 2017. | Health Services |
- Beurs
- Insiders
- Philippe Sourdille
- Ervaring